BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Vergani D, Bogdanos D. Positive markers in AMA-negative PBC. Am J Gastroenterology 2003;98:241-3. [DOI: 10.1111/j.1572-0241.2003.07270.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Rigopoulou EI, Dalekos GN. Anti‐sp100 antibodies in primary biliary cirrhosis. Scandinavian Journal of Gastroenterology 2009;39:406-7. [DOI: 10.1080/00365520310008746] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
2 Hirschfield GM, Heathcote EJ. Antimitochondrial antibody-negative primary biliary cirrhosis. Clin Liver Dis. 2008;12:323-331; viii-ix. [PMID: 18456183 DOI: 10.1016/j.cld.2008.02.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 1.4] [Reference Citation Analysis]
3 Granito A, Muratori P, Quarneti C, Pappas G, Cicola R, Muratori L. Antinuclear antibodies as ancillary markers in primary biliary cirrhosis. Expert Rev Mol Diagn 2012;12:65-74. [PMID: 22133120 DOI: 10.1586/erm.11.82] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.3] [Reference Citation Analysis]
4 Smyk D, Cholongitas E, Kriese S, Rigopoulou EI, Bogdanos DP. Primary biliary cirrhosis: family stories. Autoimmune Dis. 2011;2011:189585. [PMID: 21687641 DOI: 10.4061/2011/189585] [Cited by in Crossref: 13] [Cited by in F6Publishing: 25] [Article Influence: 1.2] [Reference Citation Analysis]
5 Granito A, Yang W, Muratori L, Lim MJ, Nakajima A, Ferri S, Pappas G, Quarneti C, Bianchi FB, Bloch DB, Muratori P. PML Nuclear Body Component Sp140 Is a Novel Autoantigen in Primary Biliary Cirrhosis. American Journal of Gastroenterology 2010;105:125-31. [DOI: 10.1038/ajg.2009.596] [Cited by in Crossref: 51] [Cited by in F6Publishing: 55] [Article Influence: 4.3] [Reference Citation Analysis]
6 Czaja AJ, Norman GL. Autoantibodies in the diagnosis and management of liver disease. J Clin Gastroenterol 2003;37:315-29. [PMID: 14506390 DOI: 10.1097/00004836-200310000-00011] [Cited by in Crossref: 41] [Cited by in F6Publishing: 34] [Article Influence: 2.3] [Reference Citation Analysis]
7 Smyk DS, Rigopoulou EI, Pares A, Billinis C, Burroughs AK, Muratori L, Invernizzi P, Bogdanos DP. Sex differences associated with primary biliary cirrhosis. Clin Dev Immunol. 2012;2012:610504. [PMID: 22693524 DOI: 10.1155/2012/610504] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 1.8] [Reference Citation Analysis]
8 Bianchi I, Lleo A, Bernuzzi F, Caliari L, Smyk DS, Invernizzi P. The X-factor in primary biliary cirrhosis: monosomy X and xenobiotics. Auto Immun Highlights 2012;3:127-32. [PMID: 26000136 DOI: 10.1007/s13317-012-0043-2] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
9 Bogdanos DP, Baum H, Butler P, Rigopoulou EI, Davies ET, Ma Y, Burroughs AK, Vergani D. Association between the primary biliary cirrhosis specific anti-sp100 antibodies and recurrent urinary tract infection. Dig Liver Dis. 2003;35:801-805. [PMID: 14674671 DOI: 10.1016/s1590-8658(03)00466-3] [Cited by in Crossref: 49] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
10 Bogdanos DP, Baum H, Vergani D. Antimitochondrial and other autoantibodies. Clin Liver Dis. 2003;7:759-777. [PMID: 14594130 DOI: 10.1016/s1089-3261(03)00104-1] [Cited by in Crossref: 71] [Cited by in F6Publishing: 28] [Article Influence: 3.9] [Reference Citation Analysis]
11 Rigopoulou EI, Dalekos GN. Molecular diagnostics of primary biliary cirrhosis. Expert Opin Med Diagn. 2008;2:621-634. [PMID: 23495774 DOI: 10.1517/17530059.2.6.621] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 1.9] [Reference Citation Analysis]
12 Smyk DS, Rigopoulou EI, Muratori L, Burroughs AK, Bogdanos DP. Smoking as a risk factor for autoimmune liver disease: what we can learn from primary biliary cirrhosis. Annals of Hepatology 2012;11:7-14. [DOI: 10.1016/s1665-2681(19)31481-4] [Cited by in Crossref: 25] [Article Influence: 2.5] [Reference Citation Analysis]
13 Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Sakkas L, Pouria S, Shoenfeld Y. Tracing environmental markers of autoimmunity: introducing the infectome. Immunol Res 2013;56:220-40. [PMID: 23592050 DOI: 10.1007/s12026-013-8399-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 3.0] [Reference Citation Analysis]
14 Bogdanos DP, Vergani D, Muratori P, Muratori L, Bianchi FB. Specificity of anti-sp100 antibody for primary biliary cirrhosis. Scand J Gastroenterol. 2004;39:405-406; author reply 407. [PMID: 15125479 DOI: 10.1080/00365520310008412] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
15 Mytilinaiou MG, Meyer W, Scheper T, Rigopoulou EI, Probst C, Koutsoumpas AL, Abeles D, Burroughs AK, Komorowski L, Vergani D, Bogdanos DP. Diagnostic and clinical utility of antibodies against the nuclear body promyelocytic leukaemia and Sp100 antigens in patients with primary biliary cirrhosis. Clinica Chimica Acta 2012;413:1211-6. [DOI: 10.1016/j.cca.2012.03.020] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.1] [Reference Citation Analysis]
16 Koutsoumpas AL, Kriese S, Rigopoulou EI. Popular and unpopular infectious agents linked to primary biliary cirrhosis. Auto Immun Highlights 2012;3:95-104. [PMID: 26000132 DOI: 10.1007/s13317-012-0039-y] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Bogdanos DP, Smyk DS, Invernizzi P, Rigopoulou EI, Blank M, Pouria S, Shoenfeld Y. Infectome: a platform to trace infectious triggers of autoimmunity. Autoimmun Rev. 2013;12:726-740. [PMID: 23266520 DOI: 10.1016/j.autrev.2012.12.005] [Cited by in Crossref: 65] [Cited by in F6Publishing: 61] [Article Influence: 6.5] [Reference Citation Analysis]
18 Smyk D, Rigopoulou EI, Bizzaro N, Bogdanos DP. Hair dyes as a risk for autoimmunity: from systemic lupus erythematosus to primary biliary cirrhosis. Auto Immun Highlights. 2013;4:1-9. [PMID: 26000137 DOI: 10.1007/s13317-011-0027-7] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
19 Muratori L, Granito A, Muratori P, Pappas G, Bianchi FB. Antimitochondrial antibodies and other antibodies in primary biliary cirrhosis: diagnostic and prognostic value. Clin Liver Dis. 2008;12:261-276; vii. [PMID: 18456179 DOI: 10.1016/j.cld.2008.02.009] [Cited by in Crossref: 49] [Cited by in F6Publishing: 36] [Article Influence: 3.5] [Reference Citation Analysis]
20 Norman GL, Bialek A, Encabo S, Butkiewicz B, Wiechowska-Kozlowska A, Brzosko M, Shums Z, Milkiewicz P. Is prevalence of PBC underestimated in patients with systemic sclerosis? Dig Liver Dis. 2009;41:762-764. [PMID: 19357001 DOI: 10.1016/j.dld.2009.01.014] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 1.9] [Reference Citation Analysis]
21 Terjung B, Spengler U. Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases. Clin Rev Allergy Immunol. 2005;28:115-133. [PMID: 15879618 DOI: 10.1385/criai:28:2:115] [Cited by in Crossref: 24] [Cited by in F6Publishing: 12] [Article Influence: 1.5] [Reference Citation Analysis]
22 Smyk DS, Orfanidou T, Invernizzi P, Bogdanos DP, Lenzi M. Vitamin D in autoimmune liver disease. Clin Res Hepatol Gastroenterol. 2013;37:535-545. [PMID: 23845396 DOI: 10.1016/j.clinre.2013.05.016] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
23 Oertelt S, Rieger R, Selmi C, Invernizzi P, Ansari AA, Coppel RL, Podda M, Leung PS, Gershwin ME. A sensitive bead assay for antimitochondrial antibodies: Chipping away at AMA-negative primary biliary cirrhosis. Hepatology. 2007;45:659-665. [PMID: 17326160 DOI: 10.1002/hep.21583] [Cited by in Crossref: 113] [Cited by in F6Publishing: 103] [Article Influence: 7.5] [Reference Citation Analysis]
24 Bogdanos DP, Invernizzi P, Mackay IR, Vergani D. Autoimmune liver serology: Current diagnostic and clinical challenges. World J Gastroenterol 2008; 14(21): 3374-3387 [PMID: 18528935 DOI: 10.3748/wjg.14.3374] [Cited by in CrossRef: 141] [Cited by in F6Publishing: 116] [Article Influence: 10.1] [Reference Citation Analysis]
25 Yang CY, Leung PS, Yang GX, Kenny TP, Zhang W, Coppel R, Norman GL, Ansari AA, Mackay IR, Worman HJ. Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent. Clin Exp Immunol. 2012;168:261-267. [PMID: 22519587 DOI: 10.1111/j.1365-2249.2012.04577.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
26 Rigopoulou EI, Smyk DS, Matthews CE, Billinis C, Burroughs AK, Lenzi M, Bogdanos DP. Epstein-barr virus as a trigger of autoimmune liver diseases. Adv Virol. 2012;2012:987471. [PMID: 22693505 DOI: 10.1155/2012/987471] [Cited by in Crossref: 28] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
27 Bauer A, Habior A. Measurement of gp210 autoantibodies in sera of patients with primary biliary cirrhosis. J Clin Lab Anal. 2007;21:227-231. [PMID: 17621358 DOI: 10.1002/jcla.20170] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 0.6] [Reference Citation Analysis]
28 Hu S, Zhao F, Wang Q, Chen WX. The accuracy of the anti-mitochondrial antibody and the M2 subtype test for diagnosis of primary biliary cirrhosis: a meta-analysis. Clin Chem Lab Med. 2014;52:1533-1542. [PMID: 24501161 DOI: 10.1515/cclm-2013-0926] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 2.7] [Reference Citation Analysis]
29 Rigamonti C, Bogdanos DP, Mytilinaiou MG, Smyk DS, Rigopoulou EI, Burroughs AK. Primary biliary cirrhosis associated with systemic sclerosis: diagnostic and clinical challenges. Int J Rheumatol 2011;2011:976427. [PMID: 22187566 DOI: 10.1155/2011/976427] [Cited by in Crossref: 25] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
30 Rigopoulou EI, Davies ET, Pares A, Zachou K, Liaskos C, Bogdanos DP, Rodes J, Dalekos GN, Vergani D. Prevalence and clinical significance of isotype specific antinuclear antibodies in primary biliary cirrhosis. Gut 2005;54:528-32. [PMID: 15753539 DOI: 10.1136/gut.2003.036558] [Cited by in Crossref: 93] [Cited by in F6Publishing: 86] [Article Influence: 5.5] [Reference Citation Analysis]
31 Czaja AJ. Autoantibodies in autoimmune liver disease. Adv Clin Chem. 2005;40:127-164. [PMID: 16355922 DOI: 10.1016/s0065-2423(05)40004-9] [Cited by in Crossref: 40] [Cited by in F6Publishing: 19] [Article Influence: 2.5] [Reference Citation Analysis]
32 Smyk DS, Rigopoulou EI, Lleo A, Abeles RD, Mavropoulos A, Billinis C, Invernizzi P, Bogdanos DP. Immunopathogenesis of primary biliary cirrhosis: an old wives' tale. Immun Ageing 2011;8:12. [PMID: 22136162 DOI: 10.1186/1742-4933-8-12] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 1.5] [Reference Citation Analysis]
33 Bogdanos DP, Smyk DS, Rigopoulou EI, Mytilinaiou MG, Heneghan MA, Selmi C, Gershwin ME. Twin studies in autoimmune disease: genetics, gender and environment. J Autoimmun. 2012;38:J156-J169. [PMID: 22177232 DOI: 10.1016/j.jaut.2011.11.003] [Cited by in Crossref: 181] [Cited by in F6Publishing: 155] [Article Influence: 16.5] [Reference Citation Analysis]
34 Bogdanos D, Vergani D, Mieli-vergani G. Overlap syndromes from pediatrics to adulthood. J Gastroenterol Hepatol 2004;19:S284-6. [DOI: 10.1111/j.1440-1746.2004.03688.x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
35 Stinton LM, Swain M, Myers RP, Shaheen AA, Fritzler MJ. Autoantibodies to GW bodies and other autoantigens in primary biliary cirrhosis. Clin Exp Immunol. 2011;163:147-156. [PMID: 21091667 DOI: 10.1111/j.1365-2249.2010.04288.x] [Cited by in Crossref: 36] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
36 Yang Z, Liang Y, Qin B, Li C, Zhong R. Clinical significance of conventional serum autoantibodies for various liver diseases in a Chinese population. Clin Biochem. 2012;45:203-206. [PMID: 21933666 DOI: 10.1016/j.clinbiochem.2011.08.1146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.4] [Reference Citation Analysis]
37 Smyk DS, Bogdanos DP, Kriese S, Billinis C, Burroughs AK, Rigopoulou EI. Urinary tract infection as a risk factor for autoimmune liver disease: From bench to bedside. Clinics and Research in Hepatology and Gastroenterology 2012;36:110-21. [DOI: 10.1016/j.clinre.2011.07.013] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 2.7] [Reference Citation Analysis]
38 Bogdanos DP, Komorowski L. Disease-specific autoantibodies in primary biliary cirrhosis. Clin Chim Acta. 2011;412:502-512. [PMID: 21185272 DOI: 10.1016/j.cca.2010.12.019] [Cited by in Crossref: 67] [Cited by in F6Publishing: 64] [Article Influence: 5.6] [Reference Citation Analysis]
39 Smyk DS, Mytilinaiou MG, Milkiewicz P, Rigopoulou EI, Invernizzi P, Bogdanos DP. Towards systemic sclerosis and away from primary biliary cirrhosis: the case of PTPN22. Auto Immun Highlights 2012;3:1-9. [PMID: 26000122 DOI: 10.1007/s13317-011-0023-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
40 Milkiewicz M, Caballería L, Smyk DS, Milkiewicz P. Predicting and preventing autoimmunity: the case of anti-mitochondrial antibodies. Auto Immun Highlights 2012;3:105-12. [PMID: 26000133 DOI: 10.1007/s13317-012-0038-z] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
41 Bogdanos DP, Liaskos C, Rigopoulou EI, Dalekos GN. Anti-mitochondrial antibodies in patients with systemic lupus erythematosus: revealing the unforeseen. Clin Chim Acta. 2006;373:183-184; author reply 185. [PMID: 16714006 DOI: 10.1016/j.cca.2006.04.001] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 0.8] [Reference Citation Analysis]